Go Pro
→ The end may be near for these iconic stocks (From Chaikin Analytics) (Ad)tc pixel Free RNR Stock Alerts

RenaissanceRe (RNR) Financials

RenaissanceRe logo
$320.50 +2.14 (+0.67%)
Closing price 07/31/2026 03:59 PM Eastern
Extended Trading
$319.98 -0.51 (-0.16%)
As of 07/31/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for RenaissanceRe

Annual Income Statements for RenaissanceRe

This table shows RenaissanceRe's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 409 481 -245 197 712 731 -73 -1,097 2,526 1,835 2,647
Consolidated Net Income / (Loss)		 542 630 -355 269 950 993 -103 -1,160 3,620 2,961 3,618
Net Income / (Loss) Continuing Operations		 542 630 -355 269 536 993 -103 -1,160 3,620 2,961 3,618
Total Pre-Tax Income 		496 630 -328 263 553 996 -114 -1,219 3,110 2,993 4,014
Total Revenue		 1,479 1,686 2,059 2,028 3,729 5,122 5,230 5,012 9,061 11,601 12,727
Net Interest Income / (Expense)		 -36 -42 -44 -47 -58 -50 -48 -48 -73 -94 -121
Total Interest Income		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Interest Expense		 36 42 44 47 58 50 48 48 73 94 121
Long-Term Debt Interest Expense		 36 42 44 47 58 50 48 48 73 94 121
Total Non-Interest Income		 1,515 1,728 2,104 2,075 3,788 5,172 5,278 5,060 9,135 11,695 12,848
Other Service Charges		 13 14 9.42 5.97 4.95 0.21 11 13 -6.15 1.93 4.32
Net Realized & Unrealized Capital Gains on Investments		 101 310 377 93 444 1,220 73 -1,286 1,670 1,597 2,943
Premiums Earned		 1,401 1,403 1,718 1,976 3,338 3,952 5,194 6,334 7,471 10,096 9,901
Total Non-Interest Expense		 982 1,055 2,388 1,765 3,176 4,126 5,344 6,231 5,951 8,608 8,713
Property & Liability Insurance Claims		 448 531 1,861 1,120 2,097 2,925 3,876 4,339 3,574 5,333 5,616
Other Operating Expenses		 296 235 19 34 94 97 41 47 128 135 82
Amortization Expense		 239 289 347 433 762 898 1,215 1,569 1,875 2,644 2,551
Other Special Charges		 - - 161 178 223 207 212 277 375 497 464
Income Tax Expense		 -46 0.34 26 -6.30 17 2.86 -11 -59 -510 33 396
Preferred Stock Dividends Declared		 22 22 22 30 37 31 33 35 35 35 35
Net Income / (Loss) Attributable to Noncontrolling Interest		 111 127 -132 42 201 231 -63 -99 1,059 1,090 935
Basic Earnings per Share		 $9.36 $11.50 ($6.15) $4.91 $16.32 $15.34 ($1.57) ($25.50) $52.40 $35.31 $56.23
Weighted Average Basic Shares Outstanding		 43.16M 41.31M 39.85M 39.73M 44.15M 50.71M 43.98M 43.72M 52.69M 49.25M 43.49M
Diluted Earnings per Share		 $9.28 $11.43 ($6.15) $4.91 $16.29 $15.31 ($1.57) ($25.50) $52.27 $35.21 $56.03
Weighted Average Diluted Shares Outstanding		 43.16M 41.31M 39.85M 39.73M 44.15M 50.71M 43.98M 43.72M 52.69M 49.25M 43.49M
Weighted Average Basic & Diluted Shares Outstanding		 43.16M 41.31M 39.85M 39.73M 44.15M 50.71M 43.98M 43.72M 52.69M 49.25M 43.49M
Cash Dividends to Common per Share		 $1.20 $1.24 $1.28 - - - - - - $1.56 $1.60

Quarterly Income Statements for RenaissanceRe

This table shows RenaissanceRe's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 1,577 365 495 1,174 -199 161 827 908 752 285 654
Consolidated Net Income / (Loss)		 1,989 618 729 1,633 -19 -25 1,164 1,332 1,148 516 978
Net Income / (Loss) Continuing Operations		 1,989 618 729 1,633 -19 -25 1,164 1,332 1,148 516 978
Total Pre-Tax Income 		1,434 634 708 1,735 -83 -71 1,341 1,481 1,264 549 1,118
Total Revenue		 3,179 2,576 2,805 3,950 2,223 3,443 3,175 3,168 2,941 2,163 2,737
Net Interest Income / (Expense)		 -61 -23 -24 -24 -71 -27 -32 -31 -31 -32 -32
Total Interest Income		 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00
Total Interest Expense		 61 23 24 24 71 27 32 31 31 32 32
Long-Term Debt Interest Expense		 - 23 24 24 - 27 32 31 31 32 32
Total Non-Interest Income		 3,240 2,599 2,829 3,974 2,293 3,470 3,207 3,198 2,973 2,195 2,769
Other Service Charges		 0.14 -0.05 0.17 0.68 1.13 0.91 2.62 0.71 0.08 1.25 4.48
Net Realized & Unrealized Capital Gains on Investments		 991 156 287 1,390 -235 749 792 764 638 10 565
Premiums Earned		 2,249 2,444 2,541 2,583 2,528 2,721 2,412 2,434 2,334 2,184 2,200
Total Non-Interest Expense		 1,745 1,942 2,097 2,215 2,306 3,514 1,834 1,687 1,678 1,614 1,619
Property & Liability Insurance Claims		 980 1,166 1,310 1,374 1,484 2,744 1,042 879 951 984 942
Other Operating Expenses		 36 39 35 26 -13 23 24 23 12 19 19
Amortization Expense		 594 631 644 690 678 647 643 660 601 522 563
Other Special Charges		 134 106 108 125 157 100 126 125 113 89 95
Income Tax Expense		 -554 15 -21 102 -64 -46 177 149 116 33 139
Preferred Stock Dividends Declared		 8.84 8.84 8.84 8.84 8.84 8.84 8.84 8.84 8.84 8.84 8.84
Net Income / (Loss) Attributable to Noncontrolling Interest		 403 245 225 450 170 -195 328 415 387 222 315
Basic Earnings per Share		 $31.54 $6.96 $9.44 $22.68 ($3.77) $3.29 $17.25 $19.47 $16.22 $6.60 $15.54
Weighted Average Basic Shares Outstanding		 52.69M 52.88M 52.16M 51.94M 49.25M 48.65M 47.07M 46.11M 43.49M 42.63M 41.55M
Weighted Average Diluted Shares Outstanding		 52.69M 52.88M 52.16M 51.94M 49.25M 48.65M 47.07M 46.11M 43.49M 42.63M 41.55M
Weighted Average Basic & Diluted Shares Outstanding		 52.69M 52.88M 52.16M 51.94M 49.25M 48.65M 47.07M 46.11M 43.49M 42.63M 41.55M

Annual Cash Flow Statements for RenaissanceRe

This table details how cash moves in and out of RenaissanceRe's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 -19 -86 940 -254 271 358 122 -665 683 -201 55
Net Cash From Operating Activities		 425 485 1,026 1,222 2,137 1,993 1,235 1,604 1,912 4,165 3,693
Net Cash From Continuing Operating Activities		 512 322 1,026 1,222 2,137 1,993 1,235 1,604 1,912 4,165 3,693
Net Income / (Loss) Continuing Operations		 542 630 -355 269 950 993 -103 -1,160 3,620 2,961 3,618
Consolidated Net Income / (Loss)		 542 630 -355 269 950 993 -103 -1,160 3,620 2,961 3,618
Depreciation Expense		 18 29 31 0.12 -59 17 -21 -27 -135 258 -14
Non-Cash Adjustments to Reconcile Net Income		 73 -147 -154 230 -415 -789 219 1,646 -490 -20 -1,199
Changes in Operating Assets and Liabilities, net		 -208 -27 1,503 723 1,661 1,772 1,140 1,145 -1,083 966 1,289
Net Cash From Investing Activities		 -339 -165 -122 -2,537 -2,989 -2,305 -816 -3,016 -3,823 -3,061 -2,216
Net Cash From Continuing Investing Activities		 -339 -165 -122 -2,537 -2,989 -2,305 -816 -3,016 -3,823 -3,061 -2,216
Purchase of Investment Securities		 -10,519 -8,470 -10,113 -14,147 -20,306 -17,638 -16,575 -52,789 -67,833 -59,398 -61,476
Sale and/or Maturity of Investments		 10,180 8,121 9,875 11,611 17,325 15,196 15,552 49,773 64,011 56,337 59,260
Net Cash From Financing Activities		 -94 -401 29 1,066 1,120 665 -302 725 2,589 -1,288 -1,411
Net Cash From Continuing Financing Activities		 -94 -401 29 1,066 1,120 665 -302 725 2,589 -1,288 -1,411
Issuance of Debt		 446 0.00 296 0.00 396 0.00 30 0.00 816 75 964
Issuance of Common Equity		 - 0.00 0.00 250 0.00 1,096 0.00 0.00 1,352 0.00 0.00
Repayment of Debt		 - 0.00 -250 0.00 0.00 -250 0.00 0.00 -30 -150 -525
Repurchase of Common Equity		 -260 -309 -189 0.00 0.00 -63 -1,028 -167 0.00 -667 -1,600
Payment of Dividends		 -76 -74 -74 -83 -96 -99 -101 -100 -110 -116 -110
Other Financing Activities, Net		 -203 -18 245 658 820 107 582 992 562 -429 -140
Effect of Exchange Rate Changes		 -11 -4.64 8.22 -5.10 2.48 4.49 6.15 22 5.54 -17 -12
Cash Interest Paid		 41 54 44 46 53 49 21 46 74 88 112

Quarterly Cash Flow Statements for RenaissanceRe

This table details how cash moves in and out of RenaissanceRe's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents		 682 -271 20 -54 104 -44 -204 273 30 -168 -261
Net Cash From Operating Activities		 512 683 1,212 1,490 779 158 1,470 1,583 483 688 852
Net Cash From Continuing Operating Activities		 512 683 1,212 1,490 779 158 1,470 1,583 483 688 852
Net Income / (Loss) Continuing Operations		 1,989 618 729 1,633 -19 -25 1,164 1,332 1,148 516 978
Consolidated Net Income / (Loss)		 1,989 618 729 1,633 -19 -25 1,164 1,332 1,148 516 978
Depreciation Expense		 -14 16 9.96 226 6.85 3.74 5.42 -6.72 -17 -24 -23
Non-Cash Adjustments to Reconcile Net Income		 -637 165 139 -843 519 -190 -185 -133 -691 420 -125
Changes in Operating Assets and Liabilities, net		 -825 -116 335 475 272 369 485 391 43 -224 22
Net Cash From Investing Activities		 -314 -304 -979 -1,497 -280 -499 -751 -1,050 85 471 -682
Net Cash From Continuing Investing Activities		 -314 -304 -979 -1,497 -280 -499 -751 -1,050 85 471 -682
Purchase of Investment Securities		 -22,432 -14,909 -18,292 -13,906 -12,370 -14,228 -11,984 -18,449 -16,814 -16,782 -19,474
Sale and/or Maturity of Investments		 22,118 14,605 17,313 12,410 12,090 13,729 11,233 17,399 16,898 17,253 18,791
Net Cash From Financing Activities		 485 -645 -209 -58 -376 290 -917 -261 -522 -1,318 -425
Net Cash From Continuing Financing Activities		 485 -645 -209 -58 -376 290 -917 -261 -522 -1,318 -425
Repurchase of Common Equity		 - 0.00 - -107 -452 -358 -374 -208 -660 -352 -350
Payment of Dividends		 -29 -29 -29 -29 -29 -28 -28 -27 -26 -26 -26
Other Financing Activities, Net		 438 -540 -146 103 154 -190 -25 9.72 65 -940 -48
Effect of Exchange Rate Changes		 -1.86 -5.21 -3.57 10 -19 7.50 -5.07 0.97 -16 -8.72 -6.20

Annual Balance Sheets for RenaissanceRe

This table presents RenaissanceRe's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 11,555 12,352 15,226 18,676 26,330 30,821 33,960 36,553 49,007 50,708 53,800
Cash and Due from Banks		 507 421 1,362 1,108 1,379 1,737 1,859 1,194 1,878 1,677 1,731
Trading Account Securities		 7,309 7,399 7,917 9,299 12,803 15,564 16,144 17,551 24,612 28,108 31,313
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accrued Investment Income		 40 38 42 51 72 67 56 122 206 238 234
Unearned Premiums Asset		 1,009 1,429 1,838 2,153 6,159 6,644 8,905 10,872 13,550 12,660 12,146
Deferred Acquisition Cost		 199 335 427 477 664 634 849 1,172 1,751 1,552 1,539
Intangible Assets		 265 251 243 237 262 250 243 238 775 704 633
Other Assets		 2,226 2,479 3,398 5,350 4,991 5,925 5,903 5,405 6,235 5,768 6,204
Total Liabilities & Shareholders' Equity		 11,555 12,352 15,226 18,676 26,330 30,821 33,960 36,553 49,007 50,708 53,800
Total Liabilities		 5,777 6,310 9,538 11,579 17,287 19,872 23,781 26,692 33,451 33,156 34,590
Short-Term Debt		 391 306 209 380 225 1,133 1,171 494 662 151 533
Long-Term Debt		 960 949 990 991 1,384 1,136 1,168 1,170 1,959 1,887 2,329
Claims and Claim Expense		 2,767 2,848 5,080 6,076 9,384 10,381 13,295 15,893 20,487 21,303 22,302
Unearned Premiums Liability		 889 1,232 1,478 1,716 2,531 2,764 3,531 4,559 6,136 5,950 6,028
Other Long-Term Liabilities		 769 976 1,782 2,416 3,763 4,458 4,616 4,576 4,208 3,864 3,397
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest		 1,046 1,176 1,297 2,052 3,071 3,388 3,554 4,535 6,101 6,978 7,602
Total Equity & Noncontrolling Interests		 4,732 4,867 4,391 5,045 5,971 7,560 6,624 5,325 9,455 10,574 11,609
Total Preferred & Common Equity		 4,732 4,867 4,391 5,045 5,971 7,560 6,624 5,325 9,455 10,574 11,609
Preferred Stock		 400 400 400 650 650 525 750 750 750 750 750
Total Common Equity		 4,332 4,467 3,991 4,395 5,321 7,035 5,874 4,575 8,705 9,824 10,859
Common Stock		 551 258 77 338 612 1,674 653 519 2,197 1,563 44
Retained Earnings		 3,779 4,208 3,914 4,058 4,711 5,374 5,233 4,071 6,522 8,276 10,827
Accumulated Other Comprehensive Income / (Loss)		 2.11 1.13 0.22 -1.43 -1.94 -13 -11 -15 -14 -15 -13

Quarterly Balance Sheets for RenaissanceRe

This table presents RenaissanceRe's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets		 38,270 41,400 40,843 50,944 51,568 52,756 53,633 54,728 54,498 53,718 55,196
Cash and Due from Banks		 1,064 944 1,196 1,607 1,627 1,573 1,633 1,429 1,702 1,563 1,302
Trading Account Securities		 18,032 19,070 19,352 24,877 26,168 28,731 28,539 28,833 29,786 31,288 32,264
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accrued Investment Income		 122 148 154 197 226 223 217 229 225 235 251
Unearned Premiums Asset		 11,771 12,367 6,958 9,714 15,081 9,424 14,230 14,822 9,347 13,184 13,701
Deferred Acquisition Cost		 1,242 1,301 1,267 1,822 1,816 1,719 1,685 1,732 1,656 1,666 1,706
Intangible Assets		 237 235 234 759 737 717 686 669 651 618 602
Other Assets		 5,802 7,242 11,683 11,968 5,913 10,369 6,644 7,014 11,131 5,166 5,370
Total Liabilities & Shareholders' Equity		 38,270 41,400 40,843 50,944 51,568 52,756 53,633 54,728 54,498 53,718 55,196
Total Liabilities		 27,047 28,321 27,592 34,854 35,053 34,653 36,595 36,885 35,527 35,161 36,032
Short-Term Debt		 389 548 812 1,428 778 607 552 492 299 309 550
Long-Term Debt		 1,141 1,882 1,883 1,884 1,960 1,936 2,754 2,263 2,229 2,330 2,331
Claims and Claim Expense		 15,997 16,138 15,955 20,370 20,741 21,221 22,857 22,914 22,713 22,291 22,269
Unearned Premiums Liability		 5,251 5,717 5,222 7,248 7,697 7,041 6,999 7,561 6,987 6,885 7,176
Other Long-Term Liabilities		 4,270 4,035 3,720 3,924 3,877 3,848 3,433 3,654 3,299 3,346 3,706
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest		 5,357 5,676 5,662 6,298 6,335 6,861 6,690 7,043 7,469 7,043 7,343
Total Equity & Noncontrolling Interests		 5,866 7,403 7,589 9,793 10,179 11,243 10,349 10,800 11,502 11,514 11,820
Total Preferred & Common Equity		 5,866 7,403 7,589 9,793 10,179 11,243 10,349 10,800 11,502 11,514 11,820
Preferred Stock		 750 750 750 750 750 750 750 750 750 750 750
Total Common Equity		 5,116 6,653 6,839 9,043 9,429 10,493 9,599 10,050 10,752 10,764 11,070
Common Stock		 512 1,876 1,888 2,190 2,101 2,011 1,196 838 652 43 42
Retained Earnings		 4,619 4,790 4,965 6,866 7,341 8,495 8,418 9,225 10,114 10,733 11,041
Accumulated Other Comprehensive Income / (Loss)		 -15 -14 -15 -14 -13 -13 -15 -14 -14 -12 -13

Annual Metrics And Ratios for RenaissanceRe

This table displays calculated financial ratios and metrics derived from RenaissanceRe's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 - - - - - - - - - - 46,109,518.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 46,109,518.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - 78.46
Growth Metrics		 - - - - - - - - - - -
Profitability Metrics		 - - - - - - - - - - -
Valuation Ratios		 - - - - - - - - - - -
Leverage & Solvency		 - - - - - - - - - - -
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Efficiency Ratios		 - - - - - - - - - - -
Capital & Investment Metrics		 - - - - - - - - - - -
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $9.36 $11.50 ($6.15) $4.91 $16.32 $15.34 ($1.57) ($25.50) $52.40 $35.31 $56.23
Adjusted Weighted Average Basic Shares Outstanding		 43.14M 40.94M 40.02M 42.21M 44.15M 50.71M 43.98M 43.72M 52.69M 49.25M 43.49M
Adjusted Diluted Earnings per Share		 $9.28 $11.43 ($6.15) $4.91 $16.29 $15.31 ($1.57) ($25.50) $52.27 $35.21 $56.03
Adjusted Weighted Average Diluted Shares Outstanding		 43.14M 40.94M 40.02M 42.21M 44.15M 50.71M 43.98M 43.72M 52.69M 49.25M 43.49M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 43.14M 40.94M 40.02M 42.21M 44.15M 50.71M 43.98M 43.72M 52.69M 49.25M 43.49M
Debt Service Ratios		 - - - - - - - - - - -
Payout Ratios		 - - - - - - - - - - -

Quarterly Metrics And Ratios for RenaissanceRe

This table displays calculated financial ratios and metrics derived from RenaissanceRe's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding		 - - - - - - - - 46,109,518.00 43,488,908.00 42,633,041.00
DEI Adjusted Shares Outstanding		 - - - - - - - - 46,109,518.00 43,488,908.00 42,633,041.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - 24.89 11.86 22.95
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 57.53% 17.48% 52.63% 116.44% -30.09% 33.66% 13.19% -19.81% - -37.18% -13.80%
EBITDA Growth		 111.09% -22.29% 110.83% 418.62% -105.37% -110.32% 87.53% -24.81% - 882.17% -18.68%
EBIT Growth		 105.27% -27.08% 85.90% 307.37% -105.80% -111.17% 89.41% -14.65% - 875.31% -16.62%
NOPAT Growth		 186.81% -26.40% 94.42% 291.97% -102.93% -108.01% 59.71% -18.43% - 1,141.03% -15.93%
Net Income Growth		 186.81% -26.40% 94.42% 291.97% -100.97% -104.08% 59.71% -18.43% - 2,142.00% -15.93%
EPS Growth		 202.60% -46.24% 130.07% 495.26% -111.95% -52.88% 82.78% -14.24% - 100.92% 0.00%
Operating Cash Flow Growth		 -30.10% 56.86% 534.83% 92.91% 51.99% -76.92% 21.22% 6.22% - 335.80% -42.00%
Free Cash Flow Firm Growth		 -376.60% -2,565.38% 10.16% 34.89% 68.44% 83.57% 93.97% 115.59% - 66.09% -157.57%
Invested Capital Growth		 57.71% 52.14% 24.14% 29.48% 7.77% 4.85% 6.99% 4.13% - 4.19% 7.02%
Revenue Q/Q Growth		 73.16% -19.55% 9.79% 40.49% -44.06% 54.92% -7.80% -0.23% - -26.46% 26.52%
EBITDA Q/Q Growth		 275.85% -54.26% 10.44% 173.12% -103.89% 12.10% 2,107.40% 9.50% - -57.95% 108.70%
EBIT Q/Q Growth		 236.84% -55.81% 11.66% 145.09% -104.79% 14.85% 1,993.82% 10.44% - -56.57% 103.66%
NOPAT Q/Q Growth		 377.41% -68.90% 17.81% 124.08% -103.56% 14.85% 2,448.51% 14.44% - -55.05% 89.66%
Net Income Q/Q Growth		 377.41% -68.90% 17.81% 124.08% -101.18% -31.42% 4,706.67% 14.44% - -55.05% 89.66%
EPS Q/Q Growth		 728.16% -77.95% 35.59% 140.38% -116.62% 186.97% 425.99% 12.79% - -59.34% 0.00%
Operating Cash Flow Q/Q Growth		 -33.65% 33.36% 77.38% 22.92% -47.73% -79.74% 831.44% 7.71% - 42.36% 23.97%
Free Cash Flow Firm Q/Q Growth		 1.05% -29.35% 50.01% -1.76% 52.05% 32.66% 81.65% 363.10% - 74.86% -39.40%
Invested Capital Q/Q Growth		 13.99% 6.75% -0.78% 7.24% -5.12% 3.85% 1.25% 4.38% - -3.97% 4.00%
Profitability Metrics		 - - - - - - - - - - -
EBITDA Margin		 44.69% 25.22% 25.37% 49.33% -3.43% -1.95% 42.40% 46.53% - 24.25% 39.99%
EBIT Margin		 45.12% 24.60% 25.02% 43.65% -3.74% -2.06% 42.22% 46.74% - 25.37% 40.84%
Profit (Net Income) Margin		 62.55% 24.01% 25.76% 41.09% -0.86% -0.73% 36.65% 42.04% - 23.85% 35.75%
Tax Burden Percent		 138.64% 97.57% 102.95% 94.12% 23.12% 35.69% 86.81% 89.95% - 93.99% 87.53%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% - 100.00% 100.00%
Effective Tax Rate		 -38.64% 2.43% -2.95% 5.88% 0.00% 0.00% 13.19% 10.05% - 6.01% 12.47%
Return on Invested Capital (ROIC)		 38.17% 14.10% 15.44% 28.20% -1.61% -0.90% 23.62% 24.05% - 13.14% 18.46%
ROIC Less NNEP Spread (ROIC-NNEP)		 38.17% 14.10% 15.44% 28.20% 0.06% -0.17% 23.62% 24.05% - 13.14% 18.46%
Return on Net Nonoperating Assets (RNNOA)		 6.43% 2.50% 2.70% 4.71% 0.01% -0.03% 3.78% 3.29% - 2.19% 2.81%
Return on Equity (ROE)		 44.60% 16.60% 18.14% 32.91% -1.60% -0.94% 27.39% 27.34% - 15.34% 21.27%
Cash Return on Invested Capital (CROIC)		 -20.41% -20.22% 0.05% 1.46% 8.19% 6.92% 7.06% 7.58% - 15.92% 11.85%
Operating Return on Assets (OROA)		 9.56% 5.21% 5.61% 11.71% -0.87% -0.49% 10.20% 10.51% - 5.41% 8.18%
Return on Assets (ROA)		 13.25% 5.08% 5.77% 11.02% -0.20% -0.17% 8.85% 9.45% - 5.09% 7.16%
Return on Common Equity (ROCE)		 23.30% 8.61% 9.86% 18.19% -0.90% -0.53% 15.53% 15.67% - 8.77% 12.14%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 34.70% 36.86% 44.19% 0.00% 22.39% 25.48% 21.31% - 36.12% 33.62%
Net Operating Profit after Tax (NOPAT)		 1,989 618 729 1,633 -58 -50 1,164 1,332 - 516 978
NOPAT Margin		 62.55% 24.01% 25.76% 41.09% -2.62% -1.44% 36.65% 42.04% - 23.85% 35.75%
Net Nonoperating Expense Percent (NNEP)		 0.00% 0.00% 0.00% 0.00% -1.67% -0.73% 0.00% 0.00% - 0.00% 0.00%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Operating Expenses to Revenue		 54.88% 75.40% 74.98% 56.35% 103.74% 102.06% 57.78% 53.26% - 74.63% 59.16%
Earnings before Interest and Taxes (EBIT)		 1,434 634 708 1,735 -83 -71 1,341 1,481 - 549 1,118
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 1,421 650 718 1,960 -76 -67 1,346 1,474 - 524 1,095
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.14 1.33 1.25 1.35 1.32 1.23 1.18 1.11 - 1.20 1.22
Price to Tangible Book Value (P/TBV)		 1.26 1.45 1.36 1.45 1.42 1.33 1.26 1.18 - 1.27 1.29
Price to Revenue (P/Rev)		 1.10 1.27 1.13 1.13 1.11 0.95 0.92 0.99 - 1.13 1.23
Price to Earnings (P/E)		 3.95 5.16 4.49 3.94 7.04 7.25 6.02 7.04 - 4.67 5.20
Dividend Yield		 0.78% 0.65% 0.69% 0.57% 0.63% 0.65% 0.65% 0.63% - 0.54% 0.51%
Earnings Yield		 25.34% 19.38% 22.26% 25.41% 14.20% 13.80% 16.61% 14.20% - 21.43% 19.23%
Enterprise Value to Invested Capital (EV/IC)		 0.97 1.07 1.04 1.10 1.07 1.03 1.02 0.98 - 1.03 1.05
Enterprise Value to Revenue (EV/Rev)		 1.94 2.20 1.92 1.81 1.81 1.68 1.63 1.74 - 1.90 2.11
Enterprise Value to EBITDA (EV/EBITDA)		 5.90 7.44 6.32 4.80 6.46 8.26 6.62 7.85 - 4.75 5.34
Enterprise Value to EBIT (EV/EBIT)		 5.65 7.22 6.25 5.05 7.02 9.15 7.17 7.87 - 4.70 5.26
Enterprise Value to NOPAT (EV/NOPAT)		 4.85 6.11 5.33 4.59 7.10 9.04 7.61 8.57 - 5.24 5.83
Enterprise Value to Operating Cash Flow (EV/OCF)		 9.19 9.61 6.29 5.85 5.05 5.75 5.37 5.26 - 5.16 6.43
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 2,337.74 85.19 13.58 15.22 14.89 13.14 - 6.59 9.17
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.17 0.21 0.17 0.14 0.12 0.19 0.15 0.13 - 0.14 0.15
Long-Term Debt to Equity		 0.13 0.12 0.12 0.11 0.11 0.16 0.13 0.12 - 0.13 0.12
Financial Leverage		 0.17 0.18 0.17 0.17 0.14 0.20 0.16 0.14 - 0.17 0.15
Leverage Ratio		 3.37 3.27 3.14 2.99 3.01 3.16 3.09 2.89 - 3.02 2.97
Compound Leverage Factor		 3.37 3.27 3.14 2.99 3.01 3.16 3.09 2.89 - 3.02 2.97
Debt to Total Capital		 14.42% 17.07% 14.22% 12.31% 10.40% 16.25% 13.38% 11.76% - 12.45% 13.07%
Short-Term Debt to Total Capital		 3.64% 7.36% 4.04% 2.94% 0.77% 2.71% 2.39% 1.39% - 1.46% 2.50%
Long-Term Debt to Total Capital		 10.78% 9.71% 10.18% 9.38% 9.63% 13.54% 10.99% 10.37% - 10.99% 10.57%
Preferred Equity to Total Capital		 4.13% 3.87% 3.90% 3.63% 3.83% 3.69% 3.64% 3.49% - 3.54% 3.40%
Noncontrolling Interests to Total Capital		 33.57% 32.46% 32.91% 33.23% 35.62% 32.88% 34.19% 34.74% - 33.23% 33.31%
Common Equity to Total Capital		 47.89% 46.60% 48.97% 50.82% 50.15% 47.18% 48.79% 50.01% - 50.78% 50.22%
Debt to EBITDA		 0.88 1.19 0.86 0.54 0.63 1.30 0.87 0.94 - 0.57 0.66
Net Debt to EBITDA		 0.25 0.61 0.35 0.20 0.11 0.66 0.42 0.31 - 0.23 0.36
Long-Term Debt to EBITDA		 0.66 0.68 0.62 0.41 0.58 1.09 0.72 0.83 - 0.51 0.54
Debt to NOPAT		 0.72 0.97 0.73 0.51 0.69 1.43 1.00 1.03 - 0.63 0.73
Net Debt to NOPAT		 0.21 0.50 0.30 0.20 0.12 0.72 0.48 0.34 - 0.26 0.40
Long-Term Debt to NOPAT		 0.54 0.55 0.52 0.39 0.64 1.19 0.82 0.91 - 0.56 0.59
Noncontrolling Interest Sharing Ratio		 47.75% 48.16% 45.66% 44.72% 44.03% 43.73% 43.31% 42.70% - 42.79% 42.93%
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -4,663 -6,031 -3,015 -3,068 -1,471 -991 -182 478 - -336 -468
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 -76.38 -261.05 0.00 0.00 -20.82 -36.58 -5.72 15.64 - -10.57 -14.74
Operating Cash Flow to Interest Expense		 8.40 29.58 0.00 0.00 11.02 5.82 46.22 51.76 - 21.63 26.82
Operating Cash Flow Less CapEx to Interest Expense		 8.40 29.58 0.00 0.00 11.02 5.82 46.22 51.76 - 21.63 26.82
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.21 0.21 0.22 0.27 0.23 0.24 0.24 0.22 - 0.21 0.20
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 18,176 19,403 19,253 20,646 19,589 20,344 20,598 21,499 - 21,196 22,045
Invested Capital Turnover		 0.61 0.59 0.60 0.69 0.61 0.63 0.64 0.57 - 0.55 0.52
Increase / (Decrease) in Invested Capital		 6,651 6,650 3,744 4,701 1,413 941 1,346 853 - 852 1,447
Enterprise Value (EV)		 17,559 20,759 20,016 22,788 21,012 20,933 20,937 20,997 - 21,795 23,183
Market Capitalization		 9,966 12,006 11,819 14,207 12,923 11,820 11,817 11,952 - 12,926 13,510
Book Value per Share		 $170.11 $171.01 $178.31 $201.18 $189.14 $194.89 $206.57 $228.45 - $247.52 $259.66
Tangible Book Value per Share		 $154.96 $156.66 $164.36 $187.42 $175.59 $180.96 $192.82 $214.61 - $233.31 $245.53
Total Capital		 18,176 19,403 19,253 20,646 19,589 20,344 20,598 21,499 - 21,196 22,045
Total Debt		 2,620 3,312 2,739 2,543 2,037 3,306 2,755 2,528 - 2,639 2,881
Total Long-Term Debt		 1,959 1,884 1,960 1,936 1,887 2,754 2,263 2,229 - 2,330 2,331
Net Debt		 743 1,706 1,111 970 361 1,673 1,327 826 - 1,076 1,579
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Net Nonoperating Expense (NNE)		 0.00 0.00 0.00 0.00 -39 -24 0.00 0.00 - 0.00 0.00
Net Nonoperating Obligations (NNO)		 2,620 3,312 2,739 2,543 2,037 3,306 2,755 2,528 - 2,639 2,881
Total Depreciation and Amortization (D&A)		 -14 16 9.96 226 6.85 3.74 5.42 -6.72 - -24 -23
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $31.54 $6.96 $9.44 $22.68 ($3.77) $3.29 $17.25 $19.47 $16.22 $6.60 $15.54
Adjusted Weighted Average Basic Shares Outstanding		 52.69M 52.88M 52.16M 51.94M 49.25M 48.65M 47.07M 46.11M 43.49M 42.63M 41.55M
Adjusted Diluted Earnings per Share		 $31.47 $6.94 $9.41 $22.62 ($3.76) $3.27 $17.20 $19.40 $16.16 $6.57 $0.00
Adjusted Weighted Average Diluted Shares Outstanding		 52.69M 52.88M 52.16M 51.94M 49.25M 48.65M 47.07M 46.11M 43.49M 42.63M 41.55M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 52.69M 52.88M 52.16M 51.94M 49.25M 48.65M 47.07M 46.11M 43.49M 42.63M 41.55M
Normalized Net Operating Profit after Tax (NOPAT)		 1,098 722 571 1,751 52 21 1,273 1,444 - 600 1,061
Normalized NOPAT Margin		 34.54% 28.03% 20.19% 44.05% 2.33% 0.60% 40.09% 45.59% - 27.72% 38.78%
Pre Tax Income Margin		 45.12% 24.60% 25.02% 43.65% -3.74% -2.06% 42.22% 46.74% - 25.37% 40.84%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 23.50 27.43 0.00 0.00 -1.18 -2.61 42.17 48.41 - 17.27 35.17
NOPAT to Interest Expense		 32.57 26.77 0.00 0.00 -0.82 -1.83 36.60 43.55 - 16.23 30.79
EBIT Less CapEx to Interest Expense		 23.50 27.43 0.00 0.00 -1.18 -2.61 42.17 48.41 - 17.27 35.17
NOPAT Less CapEx to Interest Expense		 32.57 26.77 0.00 0.00 -0.82 -1.83 36.60 43.55 - 16.23 30.79
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 3.05% 3.36% 3.08% 2.34% 3.93% 4.97% 4.14% 4.59% - 2.60% 2.67%
Augmented Payout Ratio		 3.05% 3.36% 5.97% 6.67% 26.45% 49.20% 51.01% 61.36% - 40.93% 42.20%

Financials Breakdown Chart

Key Financial Trends

RenaissanceRe’s latest quarter shows a much weaker start to 2026 compared with the strong profitability seen through much of 2024 and 2025. Q1 2026 net income attributable to common shareholders fell to $284.5 million, down sharply from $751.6 million in Q4 2025 and $907.7 million in Q3 2025. The decline was driven by lower premium earnings, weaker investment gains, and heavier operating expenses. Even so, the company remained profitable and continued to generate positive operating cash flow.

Over the last four years, RenaissanceRe has generally shown a strong earnings and cash-flow profile, but results have been highly cyclical. Premiums earned, investment income, and catastrophe/claims activity have moved around quarter to quarter, which is typical for a reinsurance business. The bigger picture is that the company has repeatedly produced strong quarters, but also occasional volatile periods, including a difficult Q1 2025 and a loss in Q4 2024.

  • Profitability remained positive in Q1 2026. The company earned $515.8 million of consolidated net income and $284.5 million attributable to common shareholders, even after a sharp drop from prior quarters.
  • Operating cash flow was solid. Q1 2026 net cash from operating activities was $687.6 million, showing the core business still generated cash despite weaker earnings.
  • The balance sheet remains large and liquid. RenaissanceRe ended Q1 2026 with $53.7 billion in total assets, including $31.3 billion in trading account securities and $1.6 billion in cash and due from banks.
  • Common equity improved year over year. Total common equity rose to $10.76 billion in Q1 2026 from $9.60 billion in Q1 2025, helped by retained earnings and stronger recent profitability.
  • Longer-term operating performance has been resilient. In 2024 and much of 2025, the company frequently posted strong quarterly earnings, including EPS above $16 in Q4 2025 and nearly $19.50 in Q3 2025.
  • Investment income remains a major swing factor. Realized and unrealized investment gains were a big contributor to revenue in several periods, but they were much smaller in Q1 2026 than in late 2025.
  • Premiums earned are still substantial but volatile. Premiums earned were $2.18 billion in Q1 2026 versus $2.33 billion in Q4 2025 and $2.43 billion in Q3 2025, suggesting some moderation in top-line growth.
  • Debt levels are manageable but worth watching. Q1 2026 short-term debt was $308.6 million and long-term debt was $2.33 billion, both below the liability base, but leverage is still part of the capital structure.
  • Q1 2026 earnings fell sharply from recent quarters. Common-share net income dropped from $751.6 million in Q4 2025 and $907.7 million in Q3 2025 to $284.5 million, signaling pressure on quarterly profitability.
  • Claims and operating expenses remain a large drag. Q1 2026 property and liability insurance claims totaled $984.0 million, while total non-interest expense was $1.61 billion, limiting margin expansion.

Looking at the trend over the past four years, the big takeaway is volatility with an overall profitable core. RenaissanceRe’s quarterly results have swung widely with underwriting results, investment gains, and catastrophe-related noise. However, the company has also shown it can quickly recover from weak quarters, which is encouraging for long-term investors. The latest quarter looks softer, but the company’s cash generation and equity base remain solid.

Bottom line: RenaissanceRe still looks financially strong overall, but Q1 2026 suggests the company is coming off a peak period and facing a more normalized or uneven earnings environment. Investors should watch premium growth, claims experience, and investment returns closely in the next few quarters.

08/01/26 01:34 AM ETAI Generated. May Contain Errors.

RenaissanceRe Financials - Frequently Asked Questions

According to the most recent income statement we have on file, RenaissanceRe's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

RenaissanceRe's net income appears to be on an upward trend, with a most recent value of $3.62 billion in 2025, rising from $542.24 million in 2015. The previous period was $2.96 billion in 2024. Find out what analysts predict for RenaissanceRe in the coming months.

Over the last 10 years, RenaissanceRe's total revenue changed from $1.48 billion in 2015 to $12.73 billion in 2025, a change of 760.6%.

RenaissanceRe's total liabilities were at $34.59 billion at the end of 2025, a 4.3% increase from 2024, and a 498.7% increase since 2015.

In the past 10 years, RenaissanceRe's cash and equivalents has ranged from $421.16 million in 2016 to $1.88 billion in 2023, and is currently $1.73 billion as of their latest financial filing in 2025.


Related Companies

Financial statements for NYSE:RNR last updated on 7/23/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
BofA: Digital Dollar Coming 2025-2030
Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...
Decentralized Masters | Sponsoredtc pixel
Elon's new "super startup"
Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...
Banyan Hill Publishing | Sponsoredtc pixel